Manufacturer Price Change Requests

Centralized Price Change Process for Generic Drugs

The pan-Canadian Pharmaceutical Alliance (pCPA) has introduced a centralized price change process and submissions can now be made directly to the pCPA for generic molecules.

This process allows manufacturers to make one submission by sending the completed request form to the pCPA instead of each individual drug plan.

The deadline for price increase requests for 1 April implementation will be 31 December 2025.

If you have questions, please reach out to the pCPA’s generics team.

Price Change Process for Brand Products

Manufacturers may submit requests for price changes by completing the request form and submit to ns.pharmacare.price.list@medavie.bluecross.ca and pharm.pricing@novascotia.ca.

When reviewing price increase requests, Nova Scotia may consider factors such as the consumer price index, pan-Canadian median pricing, previously granted price increases, supply, therapeutic class, utilization, competitors, budget impact and other relevant considerations. Nova Scotia reserves the right, at its sole discretion, to modify the methodology used for annual price reviews.

The deadline for price increase requests for 1 April implementation will be 31 December 2025.

Note: Incomplete or late submissions will not be eligible for review.

Price decreases for any product may be implemented at any time, with sufficient notice for publication.

Manufacturers are responsible for implementing price changes through wholesale and distribution networks. Nova Scotia reimburses at list price, not wholesale price.